In Vivo Brain Reprogramming with Precise Spatial and Temporal Controls

GT Biosciences is developing dual ligand lipid nanoparticles for targeted brain gene editing, allowing controllable Cas9 and sgRNA activation with IV small molecules. 

Back to Award Directory